PRO: CELL SALVAGE SHOULD BE USED IN OBSTETRICS

[1]  P. Cabrales,et al.  Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions , 2004, Transfusion.

[2]  M. Vallejo,et al.  Amniotic fluid embolism with second trimester pregnancy termination: a case report , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[3]  R. Gherman,et al.  Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. , 2001, The Journal of reproductive medicine.

[4]  E. Vamvakas.  Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma. , 2000, Transfusion medicine reviews.

[5]  A. C. Primavesi.  Amniotic Fluid Removal during Cell Salvage in the Cesarean Section Patient , 2000 .

[6]  W. Dzik,et al.  Can blood transfusion transmit disease‐producing genes? , 1999, Transfusion.

[7]  E. Turillazzi,et al.  The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase , 1998, International Journal of Legal Medicine.

[8]  P. Tazzari,et al.  Blood salvage during caesarean section. , 1998, British journal of anaesthesia.

[9]  H. Bernstein,et al.  The Ability of the Haemonetics[registered sign] 4 Cell Saver System to Remove Tissue Factor from Blood Contaminated with Amniotic Fluid , 1997, Anesthesia and analgesia.

[10]  C. Berg,et al.  Pregnancy-related mortality surveillance--United States, 1987-1990. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[11]  A. Di Lieto,et al.  [Retrospective study of postoperative infectious morbidity following cesarean section]. , 1996, Minerva ginecologica.

[12]  S. Kleinman,et al.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. , 1996, The New England journal of medicine.

[13]  S. Dzik.  Leukodepletion blood filters: filter design and mechanisms of leukocyte removal. , 1993, Transfusion medicine reviews.

[14]  R. Lonser,et al.  Safety and effectiveness of intracesarean blood salvage , 1993, Transfusion.

[15]  P. Tartter,et al.  Postoperative infections following autologous and homologous blood transfusions , 1992, Transfusion.

[16]  A. C. Mathelier.  A comparison of postoperative morbidity following prophylactic antibiotic administration by combined irrigation and intravenous route or by intravenous route alone during cesarean section , 1992, Journal of perinatal medicine.

[17]  A. Guha,et al.  Amniotic fluid contains tissue factor, a potent initiator of coagulation , 1992, American journal of obstetrics and gynecology.

[18]  N. Blumberg,et al.  Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions , 1991, Transfusion.

[19]  B. Genetet,et al.  [Rheologic and cytologic study of autologous blood collected with Cell Saver 4 during cesarean]. , 1989, Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine.

[20]  H. Perkins.  Transfusion-induced immunologic unresponsiveness. , 1988, Transfusion medicine reviews.

[21]  D. Grimes.  A simplified device for intraoperative autotransfusion. , 1988, Obstetrics and gynecology.

[22]  D. Kling,et al.  Heparin-Elimination und freies Hämoglobin nach Zellseparation und Waschen autologen Blutes mit dem Cell-Saver 4 , 1988 .

[23]  P. Tartter,et al.  Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. , 1986, American journal of surgery.

[24]  R. Yomtovian.  Autologous blood transfusion. , 1985, JAMA.

[25]  P. Terasaki,et al.  INDUCTION OF HIGH KIDNEY GRAFT SURVIVAL RATE BY MULTIPLE TRANSFUSION , 1981, The Lancet.

[26]  T. O’Neill,et al.  Heparin removal in an autotransfusor device , 1981, Transfusion.

[27]  R. Shearman,et al.  Experimental amniotic fluid embolism: mechanism and treatment. , 1962, American journal of obstetrics and gynecology.